PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Treating mild strokes with clot-busting drug could save $200 million annually, study shows

2011-02-10
(Press-News.org) CINCINNATI—Treating mild strokes with the clot-busting drug approved for severe stroke could reduce the number of patients left disabled and save $200 million a year in disability costs, according to new research from the University of Cincinnati (UC). The study led by Pooja Khatri, MD, an associate professor in the department of neurology, examined the public health impact of treating mild strokes with the clot-busting drug intravenous tissue plasminogen activator (tPA). It is being presented Wednesday, Feb. 9, in Los Angeles at International Stroke Conference 2011, the annual meeting of the American Stroke Association. The research is part of the Greater Cincinnati/Northern Kentucky Stroke Study, begun in 1993 at the UC College of Medicine, which is funded by the National Institutes of Health (NIH) and identifies all hospitalized and autopsied cases of stroke and transient ischemic attack (TIA) in a five-county region. The NIH also funded the study led by Khatri. Researchers at UC analyzed hospital records from 437 patients at 16 sites in the Greater Cincinnati/Northern Kentucky Stroke Study region in 2005, the latest period for which complete records are available. The patients arrived at the hospital within 3.5 hours of experiencing symptoms, well within the 4.5-hour window for treatment with tPA. Of those 427 patients, 247 were diagnosed with mild ischemic stroke on a stroke severity scale. Only four of the mild stroke patients (about 1.6 percent) received tPA, which is approved by the Food and Drug Administration for strokes caused by blood clots, known as ischemic strokes. It's the only acute stroke treatment proven to reduce disability, but remains untested for treating mild stroke because experts previously believed patients would recover with few lasting effects and tPA treatment carries a slight but significant risk of bleeding to the brain. Of the remaining 243 mild stroke patients in the study, 150 (62 percent) were identified as likely candidates for the drug if the mildness of their stroke was disregarded as a reason to deny tPA treatment. Excluding patients with baseline disability (estimated at 37 percent), researchers assumed that 8 percent to 13 percent of the remaining patients would regain independence after their stroke if tPA was an effective treatment for this group. Extrapolating to the U.S. population, the researchers said that if tPA proves effective for mild stroke, at least 2,000 fewer patients would be disabled from mild stroke each year. Assuming a moderate disability and conservatively estimating a lifetime cost of $100,000 per patient, at least $200 million in disability expenditures would be saved. In the last five years, researchers conducting several studies have found that about one-third of patients who experienced mild strokes remained disabled three months after initial hospitalization. "Currently, there is no standard of treatment for patients with the mildest strokes," says Khatri, a member of the UC Neuroscience Institute and division director of the acute stroke program at UC. "These findings raise the question of whether the mildest strokes should be treated with intravenous tPA." For that answer, Khatri says, more study is needed with mild stroke patients included in future trials of the effectiveness of clot-busting drugs.

### END


ELSE PRESS RELEASES FROM THIS DATE:

Sharp rise in street drug usage among stroke patients, study shows

2011-02-10
CINCINNATI—While smoking and alcohol use remained relatively stable over a 13-year study period, street drug use among stroke patients rose more than nine-fold, according to new research from the University of Cincinnati (UC). The findings are being presented Wednesday, Feb. 9, in Los Angeles at International Stroke Conference (ISC) 2011, the annual meeting of the American Stroke Association, by Felipe De los Rios, MD, of the UC Department of Neurology and the UC Neuroscience Institute. De los Rios is a fourth-year resident in the neurology department. The research is ...

Poorer patients have more severe ischemic strokes, study indicates

2011-02-10
CINCINNATI—Poorer patients have more severe ischemic strokes, or strokes resulting from blockages in blood vessels in the brain, according to new research from the University of Cincinnati (UC). A study led by Dawn Kleindorfer, MD, an associate professor in the department of neurology, found that increasing poverty in the neighborhood where the stroke patient lived was associated with worse stroke severity at presentation, independent of other known factors associated with stroke outcomes. The study is being presented Wednesday, Feb. 9, in Los Angeles at International ...

Omega 3's -- more evidence for their benefit

2011-02-10
Omega-3 fatty acids –fats commonly found in fish oil – were shown several years ago to prevent retinopathy, a major form of blindness, in a mouse model of the disease. A follow-up study, from the same research team at Children's Hospital Boston, now reveals exactly how omega-3's provide protection, and provides reassurance that widely used COX-inhibiting drugs like aspirin and NSAIDs don't negate their benefit. The findings, published in the February 9th issue of Science Translational Medicine, also suggest that omega-3's may be beneficial in diabetes. Retinopathy – an ...

Researchers at Harvard and MITRE produce world's first programmable nanoprocessor

Researchers at Harvard and MITRE produce worlds first programmable nanoprocessor
2011-02-10
Cambridge, Mass. – February 9, 2011 – Engineers and scientists collaborating at Harvard University and the MITRE Corporation have developed and demonstrated the world's first programmable nanoprocessor. The groundbreaking prototype computer system, described in a paper appearing today in the journal Nature, represents a significant step forward in the complexity of computer circuits that can be assembled from synthesized nanometer-scale components. It also represents an advance because these ultra-tiny nanocircuits can be programmed electronically to perform a number ...

Searching for the soul of the genome

2011-02-10
VIDEO: Kelly Frazer, PhD, describes genome-wide association studies and the new CAD risk findings. Click here for more information. The discovery that a "gene desert" on chromosome 9 was a hotspot for coronary artery disease (CAD) risk was among the highlights of findings produced recently by genome-wide association studies, which compare the genomes of many people for genetic variations and have been broadly used in the past few years to study hundreds of diseases and complex ...

Skin cells help to develop possible heart defect treatment in first-of-its-kind Stanford study

2011-02-10
STANFORD, Calif. — Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells — cardiomyocytes — allowed the researchers for the first time to examine and characterize the disorder at the cellular level. In a study to be published online Feb. 9 in Nature, the investigators also report their identification of a promising drug to reverse the heart malfunction — for which there are currently no decent ...

Human and mouse studies sharpen focus on cause of celiac disease

2011-02-10
Blocking a factor that can activate the human immune response against intestinal bacteria or certain foods could prevent the development of celiac disease in those most at risk, researchers report in the journal Nature. The study, to be published early online Feb. 9, points to two chemical signals—interleukin 15 and retinoic acid, a derivative of vitamin A—as triggers for the inflammatory response to gluten, a protein found in many grains that causes celiac disease. "We found that having elevated levels of IL-15 in the gut could initiate all the early stages of celiac ...

Researchers find public sector research responsible for many new drug discoveries

2011-02-10
(Boston) - Researchers from Boston University School's of Medicine (BUSM), Management (SMG) and Law (LAW), along with collaborators from the National Institutes of Health, believe that public-sector research has had a more immediate effect on improving public health than was previously realized. The findings, which appear as a Special Article in the February 10th issue of The New England Journal of Medicine, have economic and policy implications. Historically, public sector research institutions (PSRI) have not participated in any major way in the downstream, applied ...

Scientists discover gene regulation mechanism unique to primates

2011-02-10
Scientists have discovered a new way genes are regulated that is unique to primates, including humans and monkeys. Though the human genome – all the genes that an individual possesses – was sequenced 10 years ago, greater understanding of how genes function and are regulated is needed to make advances in medicine, including changing the way we diagnose, treat and prevent a wide range of diseases. "It's extremely valuable that we've sequenced a large bulk of the human genome, but sequence without function doesn't get us very far, which is why our finding is so important," ...

Scripps Research study presents surprising view of brain formation

2011-02-10
LA JOLLA, CA – Embargoed by the journal Neuron until February 9, 2011, noon, Eastern time – A study from The Scripps Research Institute has unveiled a surprising mechanism that controls brain formation. The findings have implications for understanding a host of diseases, including some forms of mental retardation, epilepsy, schizophrenia, and autism. The research, led by Scripps Research Professor Ulrich Mueller, was published in the journal Neuron on February 10, 2011. In the new study, Mueller and colleagues focused on a protein called reelin. They found reelin is ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Treating mild strokes with clot-busting drug could save $200 million annually, study shows